Illkirch, France

Aurelie Fromeyer


 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):

Title: Innovator Spotlight: Aurelie Fromeyer

Introduction

Aurelie Fromeyer, based in Illkirch, France, is an accomplished inventor recognized for her significant contributions to the field of pharmaceutical innovations. With a focus on neurodegenerative diseases, her work embodies the intersection of science and medication development, showcasing her expertise and dedication.

Latest Patents

Aurelie Fromeyer's noteworthy patent is titled "Alpha-7 Nicotinic Acetylcholine Receptor Modulators and Uses Thereof." This patent discloses compounds of Formula (IVA) and pharmaceutical formulations that include these compounds, which are designed for positive modulation of the alpha 7 nicotinic acetylcholine receptors located in the cerebral cortex and hippocampus. These innovations are believed to have therapeutic potential in treating neurodegenerative diseases such as Alzheimer's disease, schizophrenia, and Parkinson's disease, as well as movement disorders linked to certain medications used for Parkinson’s treatment.

Career Highlights

Aurelie plays an integral role at Merck Sharp & Dohme Corporation, where her work significantly contributes to advancements in medication for complex health issues. Her unique perspective and keen insights into pharmaceutical developments have furthered the understanding and treatment options for patients suffering from debilitating neurological conditions.

Collaborations

Throughout her career, Aurelie has collaborated with esteemed colleagues, including Kenneth J. Leavitt and Brendan M. Crowley. These partnerships highlight her commitment to teamwork and innovation, reflecting the collaborative spirit necessary for advancing scientific research and development in pharmaceuticals.

Conclusion

Aurelie Fromeyer's innovative work exemplifies the vital role that inventors play in the medical field. Her patent addresses critical needs in the treatment of neurodegenerative disorders, demonstrating the impact that dedicated individuals can have on public health. As she continues to refine and develop her contributions, the medical community and patients alike will undoubtedly benefit from her insights and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…